While the Dow Jones (^DJI) represents industry leaders, not every stock in the index is a safe bet. Some are facing headwinds like declining demand, rising costs, or disruptive new competitors.
Finding the best companies in the Dow Jones isn’t always straightforward, and that’s why we started StockStory. That said, here are two Dow Jones stocks that will likely remain market leaders and one that may struggle.
One Stock to Sell:
Salesforce (CRM)
Market Cap: $210.7 billion
With its cloud-based platform named after its stock ticker symbol CRM (Customer Relationship Management), Salesforce (NYSE: CRM) provides customer relationship management software that helps businesses connect with their customers across sales, service, marketing, and commerce.
Why Do We Think Twice About CRM?
- Offerings struggled to generate meaningful interest as its average billings growth of 11.2% over the last year did not impress
- Anticipated sales growth of 10.3% for the next year implies demand will be shaky
- Operating margin was unchanged over the last year, suggesting it failed to gain leverage on its fixed costs
Salesforce’s stock price of $256.46 implies a valuation ratio of 4.3x forward price-to-sales. If you’re considering CRM for your portfolio, see our FREE research report to learn more.
Two Stocks to Watch:
UnitedHealth (UNH)
Market Cap: $352.7 billion
With over 100 million people served across its various businesses and a workforce of more than 400,000, UnitedHealth Group (NYSE: UNH) operates a health insurance business and Optum, a healthcare services division that provides everything from pharmacy benefits to primary care.
Why Does UNH Stand Out?
- 10.6% annual revenue growth over the last five years was better than the sector average, highlighting the value of its products and services
- Unparalleled scale of $450.1 billion in revenue enables it to spread administrative costs across a larger membership base
- Market-beating returns on capital illustrate that management has a knack for investing in profitable ventures
UnitedHealth is trading at $392.99 per share, or 18.6x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
Visa (V)
Market Cap: $700.5 billion
Processing over 829 million transactions daily and connecting billions of cards to 150 million merchant locations worldwide, Visa (NYSE: V) operates one of the world's largest electronic payments networks, facilitating secure money movement across more than 200 countries through its VisaNet processing platform.
Why Is V a Good Business?
- 14.5% annual revenue growth over the last five years surpassed the sector average as its products resonated with customers
- Share repurchases over the last five years enabled its annual earnings per share growth of 18.8% to outpace its revenue gains
- ROE punches in at 49.2%, illustrating management’s expertise in identifying profitable investments
At $381.48 per share, Visa trades at 26.3x forward P/E. Is now the right time to buy? See for yourself in our full research report, it’s free.
Stocks We Like Even More
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.
